11/06/2024
3:05 PM | Merck & Co., Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:09 PM | Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
| Form SC 13G/A | |
11/04/2024
9:05 AM | Merck & Co., Inc. (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
10/31/2024
5:44 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
1:06 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
1:10 PM | GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
1:16 PM | Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/06/2024
11:20 AM | Guindo Chirfi (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
5:41 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
12:20 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
12:23 PM | GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
12:25 PM | Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
12:37 PM | Merck & Co., Inc. (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/25/2024
12:37 PM | Merck & Co., Inc. (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/25/2024
12:38 PM | Merck & Co., Inc. (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/04/2024
1:55 PM | Merck & Co., Inc. (Issuer)
Rothman Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:59 PM | Merck & Co., Inc. (Issuer)
Warden Kathy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
2:00 PM | Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
2:02 PM | Merck & Co., Inc. (Issuer)
RUSSO PATRICIA F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:41 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:44 PM | BAKER DOUGLAS M JR (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:44 PM | Merck & Co., Inc. (Issuer)
THULIN INGE G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:32 PM | Mayo Stephen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:34 PM | GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:38 PM | Craig Pamela J. (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
1:15 PM | LAVIZZO-MOUREY RISA J (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:39 PM | Merck & Co., Inc. (Filer)
| Form CERT | |
05/20/2024
5:28 AM | Merck & Co., Inc. (Filer)
MSD Netherlands Capital B.V. (Filer)
| Form 424B5 | |
05/15/2024
10:31 AM | Merck & Co., Inc. (Filer)
MSD Netherlands Capital B.V. (Filer)
| Form POSASR | |
05/06/2024
3:29 PM | Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
3:15 PM | Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:17 PM | Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:19 PM | Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
5:41 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:05 PM | Merck & Co., Inc. (Filer)
| Form 10-K/A | |
04/11/2024
3:08 PM | Merck & Co., Inc. (Filer)
| Form DEF 14A | |
04/11/2024
3:10 PM | Merck & Co., Inc. (Filer)
| Form DEFA14A | |
04/11/2024
3:12 PM | Merck & Co., Inc. (Filer)
| Form ARS | |
04/08/2024
12:56 PM | Larson Betty D (Reporting)
Merck & Co., Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/01/2024
4:16 PM | Inspire Investing, LLC (Filed by)
Merck & Co., Inc. (Subject)
| Form PX14A6G | |
03/29/2024
3:12 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
5 Stocks that could triple in a week (Ad) Robinhood traders have piled $78 billion into this market...
Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here. Click here to pay just $5 for a full year of Stealth Trades |
03/29/2024
3:14 PM | GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:16 PM | Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:18 PM | Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:57 PM | Bowyer Research, Inc. (Filed by)
Merck & Co., Inc. (Subject)
| Form PX14A6G | |
03/11/2024
2:27 PM | Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:24 PM | Davis Robert M (Reporting)
Merck & Co., Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
3:01 PM | Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:35 PM | Merck & Co., Inc. (Subject)
Oosthuizen Johannes Jacobus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
5:39 AM | Merck & Co., Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
2:29 PM | Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
| Form SC 13G | |
01/17/2024
4:52 PM | Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:27 PM | Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:18 PM | Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
4:27 PM | Merck & Co., Inc. (Issuer)
Smart Dalton (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
